A major breakthrough in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This essential tumor protector protein is frequently disabled in various types of malignancies, resulting https://socialevity.com/story24141121/nanobodies-revive-p53-new-promising-pathway-for-tumor-treatment